Roseola risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 6: Line 6:
==Overview==
==Overview==


The common risk factors in the development of roseola includes infancy (younger 2 years), immunosuppression, and organ transplantation.
The common risk factors in the development of roseola includes infancy (younger 2 years), [[immunosuppression]], and organ transplantation.


==Risk factors==
==Risk factors==

Revision as of 16:48, 31 May 2017

Roseola Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Roseola from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Roseola risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Roseola risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Roseola risk factors

CDC on Roseola risk factors

Roseola risk factors in the news

Blogs on Roseola risk factors

Directions to Hospitals Treating Type chapter name here

Risk calculators and risk factors for Roseola risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

The common risk factors in the development of roseola includes infancy (younger 2 years), immunosuppression, and organ transplantation.

Risk factors

Risk factors predisposing to roseola infection include:

  • Infancy: primary infection usually occurs in children less than 2 years of age
  • Immunosuppression in adults with solid organ transplants and patients with HIV infection are at a higher risk of developing complications such as encephalitis

References